Molecular mechanisms underlying neuroprotective effects of albumin after ischemic stroke.
Parkkinen
Jaakko
J
Ojala
Pauli
P
Niiranen
Jenni
J
Jolkkonen
Jukka
J
D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007262:Infusions, Intravenous; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D011485:Protein Binding / Q000502:physiology; D051381:Rats; D012709:Serum Albumin / Q000008:administration & dosage*; D020521:Stroke / Q000188:drug therapy* / Q000378:metabolism
D018696:Neuroprotective Agents; D012709:Serum Albumin